Healthcare organizations rating personal medicine as high-impacting 2016

This statistic is based on a survey conducted in 2016. It describes the percentage of healthcare organizations in North America and in Europe which evaluated the impact of personalized medicine as "significant" or "very significant" as of 2016. Some 60 percent of respondents from North American research institutions stated that their organization, at that moment, had a significant/very significant impact from personal medicine programs.

Percentage of healthcare organizations which viewed the impact of personalized medicine as significant in 2016 and 2018

Characteristic	2016	2018
North American research institutions	60%	67%
North American pharmaceutical companies	50%	60%
European research institutions	77%	77%
European pharmaceutical companies	60%	73%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

April 2016

More information

Region

North America, Europe

Survey time period

as of 2016

Number of respondents

120 healthcare professionals from research, life sciences, and clinical organizations

Supplementary notes

Original question: "To what extent will personalized medicine have an impact on your organization, today and in two years?" (“Significant impact” and “Very significant impact” responses)

Citation formats